Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas

PURPOSE: The preoperative distinction between uterine leiomyoma (LM) and leiomyosarcoma (LMS) is difficult, which may result in dissemination of an unexpected malignancy during surgery for a presumed benign lesion. An assay based on circulating tumor DNA (ctDNA) could help in the preoperative distin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Przybyl, Joanna, Spans, Lien, Lum, Deirdre A., Zhu, Shirley, Vennam, Sujay, Forgó, Erna, Varma, Sushama, Ganjoo, Kristen, Hastie, Trevor, Bowen, Raffick, Debiec-Rychter, Maria, van de Rijn, Matt
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105159/
https://ncbi.nlm.nih.gov/pubmed/32232185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00409
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars